EUVIMEDEUVIMED entdecken
Crossref

Perindopril and L‑arginine protect against arsenic trioxide–induced neurotoxicity via Keap1/Nrf2/HO‑1 activation and suppression of neuroinflammation and apoptosis

Basel A Abdel-Wahab, Ahmed M Abd-Eldayem, Ehab A M El-Shoura, Saad Misfer, Ahmed A N Ahmed, Eman K Rashwan, Hend Mostafa Selim, El-Sayed Gawesh, Olfat E Mostafa, Sabrin A Abdel Wahab, Rania A Gad

Naunyn-Schmiedeberg's Archives of Pharmacology · 2026-06 · 399 (9) · 14487-14506

DOI: 10.1007/s00210-026-05297-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 16.04.2026. Verfasst von Basel A Abdel-Wahab und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, College of Pharmacy, Najran University, Najran, P.O. Box 1988, Saudi Arabia. babdelnaem@nu.edu.sa. Hauptthemen laut MEDLINE: Arsenic Trioxide, Arginine, Perindopril, Neuroprotective Agents. Die Arbeit nennt 105 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Arsenic trioxide (ATO) remains vital in acute promyelocytic leukemia therapy, yet its clinical use is limited by cumulative organ toxicities, particularly neurotoxicity, which compromise tolerability and outcomes. Perindopril and L‑Arginine exert cytoprotective effects through antioxidant and anti‑inflammatory mechanisms. This study evaluated their neuroprotective efficacy against ATO‑induced neurotoxicity, emphasizing mechanistic pathways. Male rats were assigned to five groups: Control, ATO‑only (7.5 mg/kg, intraperitoneally, 14 days), Perindopril (2 mg/kg, orally), L‑Arginine (200 mg/kg, orally), and combined therapy. Interventions commenced seven days prior to the ATO challenge and continued for 21 days. Body weight was documented at baseline and endpoint; survival indices were monitored. Biochemical, histopathological, and molecular evaluations examined oxidative stress, inflammatory mediators, and apoptotic signaling. ATO exposure increased malondialdehyde (MDA) and nitric oxide derivatives (NOx), while reducing glutathione (GSH), superoxide dismutase (SOD), and catalase activities. It elevated tumor necrosis factor‑α (TNF‑α), interleukin‑1β (IL‑1β), and interleukin‑6 (IL‑6), while suppressing brain‑derived neurotrophic factor (BDNF) and nuclear factor erythroid 2‑related factor 2/heme oxygenase‑1 (Nrf2/HO‑1) signaling. Upregulation of Kelch‑like ECH‑associated protein 1/Nuclear factor kappa‑light‑chain‑enhancer of activated B cells (Keap1/NF‑κB), cleaved caspase‑3, and caspase‑3, alongside downregulation of B cell lymphoma‑2 (Bcl‑2), was evident. Histopathological lesions substantiated neurotoxicity. Perindopril and L‑Arginine markedly reversed these perturbations, reinstating molecular and structural homeostasis. Their combination afforded superior neuroprotection compared with monotherapies. Both agents mitigate ATO‑induced neurotoxicity through antioxidant, anti‑inflammatory, and anti‑apoptotic mechanisms, with their co‑administration surpassing individual efficacy. The Keap‑1/Nrf2/HO‑1 axis emerges as a critical therapeutic node, underscoring the translational potential of combined intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arsenic TrioxideArgininePerindoprilNeuroprotective AgentsNeuroinflammatory DiseasesNeurotoxicity SyndromesAnimalsMaleNF-E2-Related Factor 2ApoptosisKelch-Like ECH-Associated Protein 1RatsOxidative StressHeme Oxygenase (Decyclizing)AntioxidantsRats, Sprague-Dawley

Stichwörter der Autor:innen

ApoptosisArsenic TrioxideInflammationL-ArginineOxidative StressPerindopril

Substanzen

NF-E2-Related Factor 2Arsenic TrioxideArginineKelch-Like ECH-Associated Protein 1Nfe2l2 protein, ratPerindoprilNeuroprotective AgentsKEAP1 protein, ratHmox1 protein, ratHeme Oxygenase (Decyclizing)

Autor:innen und Institutionen

  • Department of Pharmacology, College of Pharmacy, Najran University, Najran, P.O. Box 1988, Saudi Arabia. babdelnaem@nu.edu.sa.
  • Department of Medical Pharmacology, Faculty of Medicine, Assiut University, Assiut, P.O. Box 71515, Egypt. dr.ahmed2016@aun.edu.eg.
  • Department of Basic Sciences, College of Medicine, Fahad Bin Sultan University, Tabuk, Saudi Arabia. dr.ahmed2016@aun.edu.eg.
  • Clinical Pharmacy Department, Faculty of Pharmacy, Al-Azhar University, Assiut, Egypt.
  • Department of Pathology, College of Medicine, The University Hospital, Najran University, Najran, Saudi Arabia.
  • Pharmacology Department, Faculty of Medicine, Al-Azhar University, Assiut, Egypt.

Zitieren

APA

Abdel-Wahab, B. A., Abd-Eldayem, A. M., El-Shoura, E. A. M., Misfer, S., Ahmed, A. A. N., Rashwan, E. K., Selim, H. M., Gawesh, E. S., Mostafa, O. E., Wahab, S. A. A., & Gad, R. A. (2026). Perindopril and L‑arginine protect against arsenic trioxide–induced neurotoxicity via Keap1/Nrf2/HO‑1 activation and suppression of neuroinflammation and apoptosis. Naunyn-Schmiedeberg's Archives of Pharmacology, 399(9), 14487-14506. https://doi.org/10.1007/s00210-026-05297-7

Vancouver

Abdel-Wahab BA, Abd-Eldayem AM, El-Shoura EAM, Misfer S, Ahmed AAN, Rashwan EK, et al. Perindopril and L‑arginine protect against arsenic trioxide–induced neurotoxicity via Keap1/Nrf2/HO‑1 activation and suppression of neuroinflammation and apoptosis. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026;399(9):14487-14506. doi:10.1007/s00210-026-05297-7

BibTeX
@article{AbdelWahab2026,
  author = {Abdel-Wahab, Basel A and Abd-Eldayem, Ahmed M and El-Shoura, Ehab A M and Misfer, Saad and Ahmed, Ahmed A N and Rashwan, Eman K and Selim, Hend Mostafa and Gawesh, El-Sayed and Mostafa, Olfat E and Wahab, Sabrin A Abdel and Gad, Rania A},
  title = {Perindopril and L‑arginine protect against arsenic trioxide–induced neurotoxicity via Keap1/Nrf2/HO‑1 activation and suppression of neuroinflammation and apoptosis},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  volume = {399},
  number = {9},
  pages = {14487--14506},
  doi = {10.1007/s00210-026-05297-7}
}
Kostenlos starten →